Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Calcium carbonate is widely used as a phosphate binder in patients on maintenance hemodialysis. An unwanted side effect of calcium carbonate is hypercalcemia and vascular calcification. Oral activated charcoal (AC) is a non-selective and highly effective adsorbent. We hypothesized that AC augments the phosphate binding capacity of calcium-based agents. We performed an in vitro study to test this hypothesis.

Methods: Simulated gastric fluid and intestinal fluid were prepared with a phosphate concentration of 10 mmol/l. Different dosages of calcium chloride (0.083 g, 0.167 g, and 0.250 g), AC (0.15 g, 0.30 g, and 0.45 g) or a combination of both were added to either gastric or intestinal fluid for phosphate binding. After a reaction time of 2 hours, phosphate concentrations in the supernatant were measured, and absolute reduction and percent reduction of phosphate were calculated. The phosphate-binding abilities of calcium chloride, AC, and a combination of both were compared.

Results: In simulated intestinal fluid there was no significant difference in the percent reduction of phosphate concentrations among the different calcium chloride concentration groups (28.90 ± 2.04 vs. 33.33 ± 3.90 vs. 31.86 ± 5.23) and there was still no significant difference in phosphate concentrations among the different AC groups (3.33 ± 0.08 vs. 3.26 ± 0.01 vs. 3.36 ± 0.11). In simulated gastric fluid phosphate concentrations at each of the time points (before the reaction, 1 hour after calcium chloride was added, and 2 hours after AC was added) were not significantly different. In simulated intestinal fluid the percent decrease in phosphate concentration in the calcium chloride + AC group was significantly higher than that in the calcium chloride group (48.23 ± 5.55 vs. 30.72 ± 6.11).

Conclusions: AC alone had no phosphate-binding ability in either gastric or intestinal fluid. The phosphate-binding ability of calcium chloride was improved by AC in intestinal fluid.

Download full-text PDF

Source
http://dx.doi.org/10.5414/CN107713DOI Listing

Publication Analysis

Top Keywords

calcium chloride
28
intestinal fluid
24
phosphate concentrations
16
phosphate-binding ability
12
phosphate
10
calcium
9
calcium-based agents
8
activated charcoal
8
calcium carbonate
8
phosphate binding
8

Similar Publications

Background: The protective function of the tetrandrine (TET)-mediated transient receptor potential vanilloid 2 (TRPV2) channel in myocardial ischemia/reperfusion injury (MI/RI) has been established in numerous investigations. The objective of the current study was to explain how TRPV2 further modulates downstream factors to influence the progression of MI/RI.

Methods: To this end, an MI/RI model in rats and a hypoxia-reoxygenation (H/R) cell model in H9c2 cells were constructed.

View Article and Find Full Text PDF

Background And Aim: Probiotic viability remains a critical challenge during gastrointestinal (GI) transit, storage, and feed processing. Conventional encapsulation materials often fail under acidic and thermal stress. This study aimed to develop and characterize a novel, eco-friendly microencapsulation system using (FP) seed extract as a natural encapsulating matrix for (LP) WU2502, enhancing its functional resilience and storage stability.

View Article and Find Full Text PDF

Patients with cystic fibrosis (CF) who are non-responsive to treatments due to specific mutations need alternative CFTR-independent therapies. This study aims to assess the impact of TMEM16a expression by a specific oligonucleotide (TMEM16a ASO) on dysregulated parameters in CF, which will help prepare for preclinical studies. In this study, we analyzed the effects of TMEM16a oligonucleotide within a CF context by evaluating the impact, optimal administration route, toxicity, and specificity in primary cells and various mouse models.

View Article and Find Full Text PDF

Outbreak of post-parturient infectious pustular vulvovaginitis in a New Zealand dairy herd.

N Z Vet J

September 2025

Diagnostics, Readiness and Surveillance, Biosecurity New Zealand, Ministry for Primary Industries, Wellington, New Zealand.

Case History: In 2023, 160/245 (65%) 2-year-old KiwiCross dairy heifers from a seasonally calving Otago herd developed severe granular vulvovaginitis after calving.

Clinical Findings: Affected heifers presented 3-12 days post-calving with tail elevation, vaginal discharge and, in most cases, vulval swelling. Heifers were afebrile although some were inappetent.

View Article and Find Full Text PDF

The activation of nucleotide oligomerization domain-like receptor (NLR) family, pyrin domain-containing protein 3 (NLRP3) inflammasome is implicated in the pathogenesis of various inflammatory diseases. The natural product oridonin possesses a novel mechanism for NLRP3 inhibition and a unique binding mode with NLRP3, but its poor anti-inflammatory activity limits further application. After virtual screening of diverse natural product libraries, dehydrocostus lactone (DCL) was considered as a potential NLRP3 inhibitor.

View Article and Find Full Text PDF